EMC
85
38
HD
35
-11
FOX
50
2
CMA
52
2
UPS
51
-2
MRO
50
11
GOOG
75
2
KR
59
10
URI
63
3
C
48
-2
CFG
56
4
DNB
46
-2
NKE
39
2
KHC
29
-2
REGN
65
2
HPE
44
-2
L
63
3
MPC
44
5
WDC
49
-4
HES
68
2
EMC
85
38
HD
35
-11
FOX
50
2
CMA
52
2
UPS
51
-2
MRO
50
11
GOOG
75
2
KR
59
10
URI
63
3
C
48
-2
CFG
56
4
DNB
46
-2
NKE
39
2
KHC
29
-2
REGN
65
2
HPE
44
-2
L
63
3
MPC
44
5
WDC
49
-4
HES
68
2
Financhill
Back

Singular Genomics Systems 10K Form

Sell
14

OMIC
Singular Genomics Systems

Last Price:
0.38
Seasonality Move:
-1.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OMIC News And Ratings

See the #1 stock for the next 7 days that we like better than OMIC

OMIC Financial Statistics

Sales & Book Value

Annual Sales: $2.91M
Cash Flow: $-23.73M
Price / Cash Flow: 0
Annual Sales: $2.12
Price / Book: 0.18

Profitability

EPS (TTM): -1.31000
Net Income (TTM): $-96.21M
Gross Margin: $-558K
Return on Equity: -48.42%
Return on Assets: -34.9%

Singular Genomics Systems Earnings Forecast

Key Singular Genomics Systems Financial Ratios

  • The Gross Profit Margin over the past 3 years for OMIC is -19.17%.
  • The Selling, General & Administrative Expenses for OMIC have been equal to 1,871.49% of Gross Profit Margin.
  • The Research & Development expenses have been 1,640.81% of Revenue.
  • The Interest Expense is -1.16% of Operating Income.
  • The Net Earning history of OMIC is -3,257.30% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Singular Genomics Systems Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: OMIC
Website: singulargenomics.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 10.35
Quick Ratio: 9.45

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OMIC Technical Analysis vs Fundamental Analysis

Sell
14
Singular Genomics Systems (OMIC) is a Sell

Is Singular Genomics Systems a Buy or a Sell?